Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ADMS

Adamas Pharmaceuticals (ADMS) Stock Price, News & Analysis

Adamas Pharmaceuticals logo

About Adamas Pharmaceuticals Stock (NASDAQ:ADMS)

Advanced Chart

Key Stats

Today's Range
$8.22
$8.22
50-Day Range
$7.97
$8.23
52-Week Range
$4.02
$9.15
Volume
N/A
Average Volume
692,487 shs
Market Capitalization
$376.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ADMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamas Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMS Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Adamas One Corp (JEWL)
See More Headlines

ADMS Stock Analysis - Frequently Asked Questions

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) issued its earnings results on Thursday, November, 11th. The specialty pharmaceutical company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by $0.21. The specialty pharmaceutical company earned $25.90 million during the quarter, compared to the consensus estimate of $25.07 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adamas Pharmaceuticals investors own include Rite Aid (RAD), VBI Vaccines (VBIV), Amarin (AMRN), Agile Therapeutics (AGRX), Dynavax Technologies (DVAX), TherapeuticsMD (TXMD) and Exelixis (EXEL).

Company Calendar

Last Earnings
11/11/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ADMS
CIK
1328143
Employees
138
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
($1.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.40 million
Net Margins
-71.11%
Pretax Margin
-71.11%
Return on Equity
N/A
Return on Assets
-42.96%

Debt

Debt-to-Equity Ratio
21.25
Current Ratio
4.53
Quick Ratio
4.17

Sales & Book Value

Annual Sales
$74.46 million
Price / Sales
5.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.47) per share
Price / Book
-17.49

Miscellaneous

Outstanding Shares
45,787,000
Free Float
37,133,000
Market Cap
$376.37 million
Optionable
Optionable
Beta
2.82

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:ADMS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners